Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022)
Prime Medicine's (PRME) quarterly Preferred Dividend Payments came in at $1.3 million in Q4 2022, down 79.35% on a QoQ basis from $6.4 million in Q3 2022.
Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022) Analysis & Trends
Prime Medicine (PRME) has 2 years of Preferred Dividend Payments data on file, last reported at $1.3 million in Q4 2022.
- Quarterly Preferred Dividend Payments changed N/A year-over-year to $1.3 million in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $1.3 million (down 93.04% YoY) and the FY2022 annual result came in at $20.2 million, up 1275.54% from the prior year.
- Preferred Dividend Payments retreated to $1.3 million in Q4 2022, from $6.4 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $6.4 million in Q3 2021 to a low of $1.3 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Prime Medicine | 558.48 Mn | 558.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 6.36 Mn |
| Jun 30, 2022 | 6.29 Mn |
| Mar 31, 2022 | 6.22 Mn |
| Sep 30, 2021 | 6.36 Mn |